Portage Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRTG and buy or sell other stocks, ETFs, and their options commission-free!About PRTG
AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists.
CEOBrittany Kaiser
CEOBrittany Kaiser
Employees—
Employees—
HeadquartersRoad Town, Tortola
HeadquartersRoad Town, Tortola
Founded1973
Founded1973
Employees—
Employees—
PRTG Key Statistics
Market cap7.60M
Market cap7.60M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume692.15K
Average volume692.15K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$15.82
52 Week high$15.82
52 Week low$1.26
52 Week low$1.26
Stock Snapshot
Portage Biotech(PRTG) stock is priced at $6.81, giving the company a market capitalization of 7.6M. It carries a P/E multiple of -0.02.
On 2025-12-14, Portage Biotech(PRTG) stock opened at —, reached a high of —, and a low of —.
The Portage Biotech(PRTG)'s current trading volume is 0, compared to an average daily volume of 692.15K.
In the last year, Portage Biotech(PRTG) shares hit a 52-week high of $15.82 and a 52-week low of $1.26.
In the last year, Portage Biotech(PRTG) shares hit a 52-week high of $15.82 and a 52-week low of $1.26.
People also own
Based on the portfolios of people who own PRTG. This list is generated using Robinhood data, and it’s not a recommendation.